Audio Journal of Oncology Podcast Erica L. Mayer MD MPH: Adjuvant Abemaciclib: Start Low, then Dose Escalate in Early-stage HR+/HER2...
Audio Journal of Oncology Podcast Patients with Early-Stage Non-Squamous Non-Small Cell Lung Cancer Who can Benefit from Adjuvant...
“Adjuvant nivolumab added to chemoradiotherapy after surgery provided a statistically and clinically meaningful disease-free survival...
Luis G Paz-Ares MD PhD discdusses the addition of lurbinectedin as maintenance therapy for extensive stage small cell lung cancer (SCLC)
Audio Journal of Oncology Podcast Elena Elez, Barcelona, ASCO: BRAF Inhibitor Encorafenib Delays Progression, Extends Survival in Patients...
Yelena Y. Janjigian MD says that perioperative anti-PD-L1 immunotherapy with durvalumab was a "game changer" meriting use as a new standard...
Exercise was as good as the addition of a drug among patients with high risk stage 2 or stage 3 colon cancer after curative surgery...
Audio Journal of Oncology Podcast Frank A Sinicrope MD: Stage 3 Colon Cancer with Deficient Mismatch Repair: Big Gains from Atezolizumab...
Andy Zeng, Toronto: Transcriptome Map Key to Malignant Transformation in AML
Yelena Y Janjigian MD talks about the use of ctDNA to direct immunotherapy among patients with mismatch repair deficient solid tumors.
Paolo Marchetti MD, Scientific Director, Istituto Dermatopatico dell'Immacolata, Rome
Audio Journal of Oncology Podcast Patients with Relapsed or Refractory Acute Myeloid Leukemia have Remissions with “Logic Gated” Off-the...